Evidence map›Paper›PMID 39704505›Full record

ArticleMedical physics2025

Predicting early stage lung cancer recurrence and survival from combined tumor motion amplitude and radiomics on free-breathing 4D-CT.

Emilie Ouraou, Marion Tonneau, William T Le, Edith Filion, Marie-Pierre Campeau, Toni Vu, Robert Doucet, Houda Bahig, Samuel Kadoury

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emilie OuraouComputer and Software Engineering Department, Polytechnique Montréal, Montréal, Quebec, Canada.
Marion TonneauRadiation Oncology Department, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
William T LeComputer and Software Engineering Department, Polytechnique Montréal, Montréal, Quebec, Canada.
Edith FilionRadiation Oncology Department, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Marie-Pierre CampeauRadiation Oncology Department, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Toni VuRadiation Oncology Department, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Robert DoucetRadiation Oncology Department, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Houda BahigRadiation Oncology Department, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Samuel KadouryComputer and Software Engineering Department, Polytechnique Montréal, Montréal, Quebec, Canada.

Funding

Varian Medical Systems
6 · The paper itself

Abstract

backgroundCancer control outcomes of lung cancer are hypothesized to be affected by several confounding factors, including tumor heterogeneity and patient history, which have been hypothesized to mitigate the dose delivery effectiveness when treated with radiation therapy. Providing an accurate predictive model to identify patients at risk would enable tailored follow-up strategies during treatment. PURPOSE: Our goal is to demonstrate the added prognostic value of including tumor displacement amplitude in a predictive model that combines clinical features and computed tomography (CT) radiomics for 2-year recurrence and survival in non-small-cell lung cancer (NSCLC) patients treated with curative-intent stereotactic body radiation therapy.

methodsA cohort of 381 patients treated for primary lung cancer with radiotherapy was collected, each including a planning CT with a dosimetry plan, 4D-CT, and clinical information. From this cohort, 101 patients (26.5%) experienced cancer progression (locoregional/distant metastasis) or death within 2 years of the end of treatment. Imaging data was analyzed for radiomics features from the tumor segmented image, as well as tumor motion amplitude measured on 4D-CT. A random forest (RF) model was developed to predict the overall outcomes, which was compared to three other approaches - logistic regression, support vector machine, and convolutional neural networks.

resultsA 6-fold cross-validation study yielded an area under the receiver operating characteristic curve of 72% for progression-free survival when combining clinical data with radiomics features and tumor motion using a RF model (72% sensitivity and 81% specificity). The combined model showed significant improvement compared to standard clinical data. Model performances for loco-regional recurrence and overall survival sub-outcomes were established at 73% and 70%, respectively. No comparative methods reached statistical significance in any data configuration.

conclusionsCombined tumor respiratory motion and radiomics features from planning CT showed promising predictive value for 2-year tumor control and survival, indicating the potential need for improving motion management strategies in future studies using machine learning-based prognosis models.

Indexed as

Carcinoma, Non-Small-Cell LungFour-Dimensional Computed TomographyLung NeoplasmsNeoplasm Recurrence, LocalRespirationAgedAged, 80 and overFemaleHumansMaleMiddle AgedMovementNeoplasm StagingRadiomicsoutcome predictionradiomicstumor motion

Identifiers

PMID39704505
PMCPMC11880644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.